BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 37821969)

  • 1. Association between remnant cholesterol, metabolic syndrome, and cardiovascular disease: post hoc analysis of a prospective national cohort study.
    Jin J; Hu X; Francois M; Zeng P; Wang W; Yu B; Zhou Y; Dong H
    Eur J Med Res; 2023 Oct; 28(1):420. PubMed ID: 37821969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between metabolic syndrome and its components and cardiovascular disease in middle-aged and elderly Chinese population: a national cross-sectional survey.
    Li W; Song F; Wang X; Wang D; Chen D; Yue W; Zhang H; Wang Z; Lu Z
    BMJ Open; 2019 Aug; 9(8):e027545. PubMed ID: 31427317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk for cardiovascular disease associated with metabolic syndrome and its components: a 13-year prospective study in the RIVANA cohort.
    Guembe MJ; Fernandez-Lazaro CI; Sayon-Orea C; Toledo E; Moreno-Iribas C;
    Cardiovasc Diabetol; 2020 Nov; 19(1):195. PubMed ID: 33222691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic Syndrome Components and Long-Term Incidence of Cardiovascular Disease in Eastern Mediterranean Region: A 13-Year Population-Based Cohort Study.
    Mansourian M; Babahajiani M; Jafari-Koshki T; Roohafza H; Sadeghi M; Sarrafzadegan N
    Metab Syndr Relat Disord; 2019 Sep; 17(7):362-366. PubMed ID: 31188051
    [No Abstract]   [Full Text] [Related]  

  • 5. Differential impact of serum glucose, triglycerides, and high-density lipoprotein cholesterol on cardiovascular risk factor burden in nondiabetic, obese African American women: implications for the prevalence of metabolic syndrome.
    Gaillard T; Schuster D; Osei K
    Metabolism; 2010 Aug; 59(8):1115-23. PubMed ID: 20051282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of, risk factors for, and target organ damage from metabolic syndrome among people living with HIV on ART: A cross-sectional analysis in Chongqing, China.
    Liu M; He K; Wu Y; Yu Q; Sun N; Teng X; Meng X; Yuan J; Yang H
    HIV Med; 2024 May; 25(5):529-539. PubMed ID: 38158594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Remnant cholesterol can identify individuals at higher risk of metabolic syndrome in the general population.
    Zou Y; Kuang M; Zhong Y; Jiang C
    Sci Rep; 2023 Apr; 13(1):5957. PubMed ID: 37045908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic syndrome and cardiovascular disease in older people: The cardiovascular health study.
    McNeill AM; Katz R; Girman CJ; Rosamond WD; Wagenknecht LE; Barzilay JI; Tracy RP; Savage PJ; Jackson SA
    J Am Geriatr Soc; 2006 Sep; 54(9):1317-24. PubMed ID: 16970637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discordance between Remnant Cholesterol and Low-density Lipoprotein Cholesterol Predicts Cardiovascular Disease: the Kailuan Prospective Cohort Study.
    Zhang Y; Wu S; Tian X; Xu Q; Xia X; Zhang X; Li J; Chen S; Liu F; Wang A
    Hellenic J Cardiol; 2024 Jun; ():. PubMed ID: 38838914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of the metabolic score for insulin resistance on cardiovascular disease: a 10-year follow-up cohort study.
    Wu Z; Cui H; Zhang Y; Liu L; Zhang W; Xiong W; Lu F; Peng J; Yang J
    J Endocrinol Invest; 2023 Mar; 46(3):523-533. PubMed ID: 36125732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypertension, remnant cholesterol and cardiovascular disease: evidence from the China health and retirement longitudinal study.
    Zheng X; Han L; Shen S
    J Hypertens; 2022 Nov; 40(11):2292-2298. PubMed ID: 35950988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monocyte-to-high-density lipoprotein ratio and systemic inflammation response index are associated with the risk of metabolic disorders and cardiovascular diseases in general rural population.
    Wang P; Guo X; Zhou Y; Li Z; Yu S; Sun Y; Hua Y
    Front Endocrinol (Lausanne); 2022; 13():944991. PubMed ID: 36157453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating irisin in relation to insulin resistance and the metabolic syndrome.
    Park KH; Zaichenko L; Brinkoetter M; Thakkar B; Sahin-Efe A; Joung KE; Tsoukas MA; Geladari EV; Huh JY; Dincer F; Davis CR; Crowell JA; Mantzoros CS
    J Clin Endocrinol Metab; 2013 Dec; 98(12):4899-907. PubMed ID: 24057291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of serum concentrations of remnant cholesterol with incident cardiovascular disease in patients with rheumatoid arthritis: A real-world data from 2001 to 2022.
    Zou YW; Wu T; Li QH; Ma JD; Pan J; Lu Y; Lin JZ; Jia PW; Zheng HW; Gao JW; Dai W; Mo YQ; Dai J; Dai L
    Int J Cardiol; 2024 Jun; 405():131947. PubMed ID: 38458390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular Health Status and Metabolic Syndrome in Adults Living in a Transition European Country: Findings from a Population-Based Study.
    Stojisavljević D; Janković J; Erić M; Marinković J; Janković S
    J Stroke Cerebrovasc Dis; 2018 Mar; 27(3):568-574. PubMed ID: 29097061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between metabolic syndrome severity score and cardiovascular disease: results from a longitudinal cohort study on Chinese adults.
    Lin JJ; Dai PY; Zhang J; Guan YQ; Gong WW; Yu M; Fang L; Hu RY; He QF; Li N; Wang LX; Liang MB; Zhong JM
    Front Endocrinol (Lausanne); 2024; 15():1341546. PubMed ID: 38654930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of expression of selenoprotein P in mRNA and protein levels with metabolic syndrome in subjects with cardiovascular disease: Results of the Selenegene study.
    Gharipour M; Sadeghi M; Salehi M; Behmanesh M; Khosravi E; Dianatkhah M; Haghjoo Javanmard S; Razavi R; Gharipour A
    J Gene Med; 2017 Mar; 19(3):. PubMed ID: 28190280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of predictability of cardiovascular events between each metabolic component in patients with metabolic syndrome based on the revised National Cholesterol Education Program criteria.
    Hwang IC; Kim KK; Jee SH; Kang HC
    Yonsei Med J; 2011 Mar; 52(2):220-6. PubMed ID: 21319338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mets-IR as a predictor of cardiovascular events in the middle-aged and elderly population and mediator role of blood lipids.
    Qian T; Sheng X; Shen P; Fang Y; Deng Y; Zou G
    Front Endocrinol (Lausanne); 2023; 14():1224967. PubMed ID: 37534205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cumulative exposure to high remnant-cholesterol concentrations increases the risk of cardiovascular disease in patients with hypertension: a prospective cohort study.
    Wu W; Chen G; Wu K; Zheng H; Chen Y; Wang X; Huang Z; Cai Z; Cai Z; Chen Z; Lan Y; Chen S; Wu S; Chen Y
    Cardiovasc Diabetol; 2023 Sep; 22(1):258. PubMed ID: 37735420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.